Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders

Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression

(2020) Xiaoyun Guo et al.   NEUROPHARMACOLOGY

Glutamatergic Modulators in Depression

(2018) Ioline D. Henter et al.   HARVARD REVIEW OF PSYCHIATRY

Running Changes the Brain: the Long and the Short of It

(2017) Carmen Vivar et al.   PHYSIOLOGY

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

(2016) Jaskaran B. Singh et al.   BIOLOGICAL PSYCHIATRY

Acute Modulation of Cortical Glutamate and GABA Content by Physical Activity

(2016) Richard J. Maddock et al.   JOURNAL OF NEUROSCIENCE

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders

(2016) Rafael T de Sousa et al.   NEUROPSYCHOPHARMACOLOGY

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

(2015) D. Jeffrey Newport et al.   AMERICAN JOURNAL OF PSYCHIATRY

Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: Meta-analysis of absolute prefrontal neuro-metabolic concentrations

(2015) Danilo Arnone et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Single-Dose Ketamine Followed by Daily d-Cycloserine in Treatment-Resistant Bipolar Depression

(2015) Joshua T. Kantrowitz et al.   JOURNAL OF CLINICAL PSYCHIATRY

Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent

(2015) SHELDON PRESKORN et al.   Journal of Psychiatric Practice

Glutamate as a neurotransmitter in the healthy brain

(2014) Y. Zhou et al.   JOURNAL OF NEURAL TRANSMISSION

Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression

(2013) Chih-Chia Huang et al.   BIOLOGICAL PSYCHIATRY

A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder

(2013) Kate M. Chitty et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

(2013) Joseph R Moskal et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Brain Changes in Long-Term Zen Meditators Using Proton Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging: A Controlled Study

(2013) Nicolás Fayed et al.   PLoS One

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis

(2012) Alexandre Duarte Gigante et al.   BIPOLAR DISORDERS

Fear Conditioning and Long-term Potentiation in the Amygdala

(2008) P. Sah et al.   Annals of the New York Academy of Sciences

The glutamate story

(2006) Jeffrey C Watkins et al.   BRITISH JOURNAL OF PHARMACOLOGY